Entera Bio Ltd. Quarterly Operating Income (Loss) in USD from Q1 2021 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Entera Bio Ltd. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2021 to Q2 2024.
  • Entera Bio Ltd. Operating Income (Loss) for the quarter ending June 30, 2024 was -$2.17M, a 7.08% increase year-over-year.
  • Entera Bio Ltd. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$8.58M, a 18.1% increase year-over-year.
  • Entera Bio Ltd. annual Operating Income (Loss) for 2023 was -$8.89M, a 31.7% increase from 2022.
  • Entera Bio Ltd. annual Operating Income (Loss) for 2022 was -$13M, a 6.55% decline from 2021.
  • Entera Bio Ltd. annual Operating Income (Loss) for 2021 was -$12.2M, a 9.39% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$8.58M -$2.17M +$165K +7.08% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-09
Q1 2024 -$8.74M -$2.06M +$150K +6.78% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 -$8.89M -$1.96M +$1.11M +36% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-08
Q3 2023 -$10M -$2.39M +$479K +16.7% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 -$10.5M -$2.33M +$919K +28.3% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q1 2023 -$11.4M -$2.21M +$1.62M +42.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 -$13M -$3.07M +$1.02M +25% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-08
Q3 2022 -$14M -$2.87M +$355K +11% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$14.4M -$3.25M -$679K -26.4% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-11
Q1 2022 -$13.7M -$3.84M -$1.5M -64% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-05
Q4 2021 -$12.2M -$4.09M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 -$3.22M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$2.57M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 -$2.34M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.